Simulations Plus (SLP) Earnings Due After the Bell July 9
As seen on the 24/7 Wall St. homepage on July 9, 2026.
Simulations Plus reports after the bell as FDA's Operation TrialBlazer puts biosimulation tools in regulatory spotlights—watch whether the software segment captures that momentum.
Continue ReadingShow less
Simulations Plus is set to release its results at 4:05 PM ET on July 9, with the report confirmed for after the market close. The timing puts the company in focus at a moment when biosimulation tools are drawing unusual regulatory attention, thanks to FDA's Operation TrialBlazer initiative, which has placed software-driven drug modeling squarely in the spotlight.
The key thing to watch when the numbers land is whether the software segment has been able to capture any of that tailwind. Biosimulation platforms are central to Simulations Plus's business, and a regulatory push that validates their use in the drug development process could show up in demand metrics, contract wins, or forward guidance.
Sponsored
_________________________________
What's Your Number...?
Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________
Because the release lands after the close, any meaningful market reaction will play out in after-hours trading and carry into the following session. Investors will want to listen closely to management's commentary on the regulatory environment alongside the headline figures.
Sources
Mentioned: SLP